Dawn Klemow-Reed, M.D.

  • Internal Medicine - Hematology/Oncology
  • Medical Treatment of Breast Cancer
  • Breast Cancers

Biography

A medical oncologist, Dawn Klemow-Reed, M.D., specializes in the areas of breast cancer and benign hematology. Her primary emphasis is determining therapeutic approaches to eliminate cancer cells and prevent their spread throughout the body.

Based on her experience and knowledge of new breast cancer therapeutics, Dr. Klemow-Reed offers a comprehensive range of treatment options to patients. This includes both traditional and new alternatives – chemotherapy drugs, biologic agents, and hormonal therapy. Her expertise includes presenting alternatives with less toxicity than conventional chemotherapy.

Dr. Klemow-Reed says the team approach that UT Southwestern Medical Center applies to evaluating and treating breast cancer offers patients a significant advantage – whether the case is common or highly rare and complex. Because a group of specialists is fighting the cancer, the best possible solutions are presented to help the patient. This can include new technology, genetics counseling, and clinical trials – whatever is appropriate for the case.

Dr. Klemow-Reed completed fellowship training at UT Southwestern in medical oncology. She also completed fellowships at the University of Kansas School of Medicine in hematology and oncology, along with her internship. She received her medical degree from the University of Texas Medical Branch at Galveston.

Meet Dr. Klemow-Reed

Breast Cancer Chemotherapy & Treatment Specialist

Dawn Klemow-Reed, M.D., is on a mission – combining the best medical advancements available to treat cancer with a personalized approach to care. She’s a medical oncologist, with a focus on breast cancer. Patients can rely on Dr. Klemow-Reed to provide groundbreaking chemotherapy, hormonal therapy, and biologic agents to eliminate cancer cells and prevent their spread throughout the body.

"I am dedicated to offering my patients the best possible options for their situations – and making sure they know what to expect during and after treatment. This is extremely important, with all the developments in medical oncology diminishing the issues people feared about cancer treatment.“

Her commitment includes guiding patients through highly customized treatment plans, based on a comprehensive range of options. “I don’t generalize about cancer therapies,” she says. “I evaluate each patient on an individual basis, including the stage and type of cancer diagnosed.”

Dr. Klemow-Reed stresses that new cancer therapies are being discovered very quickly. This increases the importance for patients to receive care at a facility aware of discoveries, as well as one that leads many of them. In North Texas, many of the newer alternatives are only available at UT Southwestern Medical Center, including certain clinical trials.

As an example, she explains that newer biologic agents can target and attack cancer cells without harming noncancerous tissue. “They are less toxic than traditional chemotherapy drugs,” she says. “As a result, most patients experience fewer of the negative side effects commonly associated with cancer treatment, such as hair loss.” Examples of these targeted therapies include tyrosine kinase inhibitors, monoclonal antibodies, and PARP inhibitors.

One of the benefits UT Southwestern offers patients is a team environment – which results in exceptional cancer treatment, along with very personalized support services. Dr. Klemow-Reed advocates combining customized treatment plans with exceptional support services to address the unique needs of each individual patient, as well as their families. This ranges from psychologists to nutritionists.

See More

Education & Training
  • Medical School - UT Medical Branch at Galveston (1977-1981)
  • Fellowship - UT Southwestern Medical Center (1991-1993), Medical Oncology
  • Fellowship - University of Kansas School of Medicine (1986-1988), Hematology Oncology
  • Residency - University of Kansas School of Medicine (1982-1984), Internal Medicine
  • Internship - University of Kansas School of Medicine (1981-1982), Internal Medicine
Professional Associations & Affiliations
  • American Medical Association
  • American college of Physicians

Clinical Focus

  • Medical Treatment of Breast Cancer
  • Breast Cancers

See More

Q&A by Dr. Klemow-Reed